Generics 2

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Zolmitriptan manufacturers

2 products found

Filters

Filters

Filters , active

Country of origin : Switzerland

Clear all

2 products found

zolmitriptan

Tablets, orally disintegrating (ODT) 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Estonia , Germany , Latvia , Lithuania , United Kingdom , Vietnam
Available for
Distribution only
Comments
Ref. Zomig
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

Want to see all 2 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Zolmitriptan is a medication used to treat severe migraines. Suppliers of zolmitriptan market it in the form of 2.5mg and 5mg tablets, as well as nasal sprays. Alternatives to zolmitriptan are other triptan class medications, namely, sumatriptan, naratriptan, rizatriptan, almotriptan, eletriptan, and frovatriptan. The drug was first introduced into the pharmaceutical market in 1997 and has since then become approved in over 100 countries globally, including but not limited to geographical markets China, Australia, Japan, Brazil, as well as across Europe. The largest manufacturers and suppliers of zolmitriptan medications are companies Sun Pharmaceuticals, Teva, and AstraZeneca. Following patent expiry in 2013, other manufacturers launched their generic formulations of zolmitriptan. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified zolmitriptan manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Retail prices for 6 (2.5mg) tablets of zolmitriptan are approximately 30 EUR to 40 EUR.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible